172 related articles for article (PubMed ID: 33034833)
21. Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile.
Gonçalves C; Decré D; Barbut F; Burghoffer B; Petit JC
J Clin Microbiol; 2004 May; 42(5):1933-9. PubMed ID: 15131151
[TBL] [Abstract][Full Text] [Related]
22. Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010.
Azimirad M; Azizi O; Alebouyeh M; Aslani MM; Mousavi SF; Zali MR
Infect Genet Evol; 2019 Jul; 71():205-210. PubMed ID: 30902742
[TBL] [Abstract][Full Text] [Related]
23.
Simpson M; Bilverstone T; Leslie J; Donlan A; Uddin MJ; Petri WA; Marin N; Kuehne S; Minton NP; Petri WA
Open Forum Infect Dis; 2023 Mar; 10(3):ofad040. PubMed ID: 36895287
[TBL] [Abstract][Full Text] [Related]
24. Tailored cyclodextrin pore blocker protects mammalian cells from clostridium difficile binary toxin CDT.
Roeder M; Nestorovich EM; Karginov VA; Schwan C; Aktories K; Barth H
Toxins (Basel); 2014 Jul; 6(7):2097-114. PubMed ID: 25029374
[TBL] [Abstract][Full Text] [Related]
25. An Update on
Martínez-Meléndez A; Cruz-López F; Morfin-Otero R; Maldonado-Garza HJ; Garza-González E
Toxins (Basel); 2022 Apr; 14(5):. PubMed ID: 35622552
[TBL] [Abstract][Full Text] [Related]
26. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
[TBL] [Abstract][Full Text] [Related]
27. Membrane translocation of binary actin-ADP-ribosylating toxins from Clostridium difficile and Clostridium perfringens is facilitated by cyclophilin A and Hsp90.
Kaiser E; Kroll C; Ernst K; Schwan C; Popoff M; Fischer G; Buchner J; Aktories K; Barth H
Infect Immun; 2011 Oct; 79(10):3913-21. PubMed ID: 21768281
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for substrate recognition in the enzymatic component of ADP-ribosyltransferase toxin CDTa from Clostridium difficile.
Sundriyal A; Roberts AK; Shone CC; Acharya KR
J Biol Chem; 2009 Oct; 284(42):28713-9. PubMed ID: 19692332
[TBL] [Abstract][Full Text] [Related]
29. Interaction of the Clostridium difficile Binary Toxin CDT and Its Host Cell Receptor, Lipolysis-stimulated Lipoprotein Receptor (LSR).
Hemmasi S; Czulkies BA; Schorch B; Veit A; Aktories K; Papatheodorou P
J Biol Chem; 2015 May; 290(22):14031-44. PubMed ID: 25882847
[TBL] [Abstract][Full Text] [Related]
30. Association between Clostridioides difficile ribotypes, restriction endonuclease analysis types, and toxin gene expression.
Watanabe H; Koizumi Y; Matsumoto A; Asai N; Yamagishi Y; Mikamo H
Anaerobe; 2018 Dec; 54():140-143. PubMed ID: 30201540
[TBL] [Abstract][Full Text] [Related]
31. Predominance of Clostridioides difficile PCR ribotype 181 in northern Greece, 2016-2019.
Kachrimanidou M; Metallidis S; Tsachouridou O; Harmanus C; Lola V; Protonotariou E; Skoura L; Kuijper E
Anaerobe; 2022 Aug; 76():102601. PubMed ID: 35688364
[TBL] [Abstract][Full Text] [Related]
32. Characterization of Clostridioides difficile DSM 101085 with A-B-CDT+ Phenotype from a Late Recurrent Colonization.
Riedel T; Neumann-Schaal M; Wittmann J; Schober I; Hofmann JD; Lu CW; Dannheim A; Zimmermann O; Lochner M; Groß U; Overmann J
Genome Biol Evol; 2020 May; 12(5):566-577. PubMed ID: 32302381
[TBL] [Abstract][Full Text] [Related]
33. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile.
Stubbs S; Rupnik M; Gibert M; Brazier J; Duerden B; Popoff M
FEMS Microbiol Lett; 2000 May; 186(2):307-12. PubMed ID: 10802189
[TBL] [Abstract][Full Text] [Related]
34. Binary toxin producing Clostridium difficile strains.
Rupnik M; Grabnar M; Geric B
Anaerobe; 2003 Dec; 9(6):289-94. PubMed ID: 16887714
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile.
Gülke I; Pfeifer G; Liese J; Fritz M; Hofmann F; Aktories K; Barth H
Infect Immun; 2001 Oct; 69(10):6004-11. PubMed ID: 11553537
[TBL] [Abstract][Full Text] [Related]
36. Detection and elimination of a novel non-toxigenic
Maslanka JR; Gu CH; Zarin I; Denny JE; Broadaway S; Fett B; Mattei LM; Walk ST; Abt MC
Gut Microbes; 2020 Nov; 12(1):1-15. PubMed ID: 33305657
[No Abstract] [Full Text] [Related]
37. Structural insights into the transition of Clostridioides difficile binary toxin from prepore to pore.
Anderson DM; Sheedlo MJ; Jensen JL; Lacy DB
Nat Microbiol; 2020 Jan; 5(1):102-107. PubMed ID: 31712627
[TBL] [Abstract][Full Text] [Related]
38. The Binary Toxin of
Stieglitz F; Gerhard R; Pich A
Front Microbiol; 2021; 12():725612. PubMed ID: 34594315
[No Abstract] [Full Text] [Related]
39. Human α-Defensin-5 Efficiently Neutralizes
Korbmacher M; Fischer S; Landenberger M; Papatheodorou P; Aktories K; Barth H
Front Pharmacol; 2020; 11():1204. PubMed ID: 32903430
[TBL] [Abstract][Full Text] [Related]
40. Human peptide α-defensin-1 interferes with Clostridioides difficile toxins TcdA, TcdB, and CDT.
Fischer S; Ückert AK; Landenberger M; Papatheodorou P; Hoffmann-Richter C; Mittler AK; Ziener U; Hägele M; Schwan C; Müller M; Kleger A; Benz R; Popoff MR; Aktories K; Barth H
FASEB J; 2020 May; 34(5):6244-6261. PubMed ID: 32190927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
